Healthcare Industry News: Edwards Lifesciences
News Release - November 12, 2007
The Edwards Lifesciences Fund Awards More Than $2.5 Million in Charitable Grants
IRVINE, Calif., Nov. 12 (HSMN NewsFeed) -- Edwards Lifesciences Corporation (NYSE: EW ), a world leader in products and technologies to treat advanced cardiovascular disease, announced today the 2007 grant recipients from The Edwards Lifesciences Fund, a philanthropic, donor-advised fund the company established in 2005. As part of the Fund's third annual grant cycle, more than 60 charitable organizations received grants between $5,000 and $100,000, bringing the yearly total to more than $2.5 million."We are proud that this year we are more than doubling the amount of money granted in 2006, and are also increasing the number of organizations supported by our Fund by nearly 40 percent," said Michael A. Mussallem, Edwards' chairman and CEO. "The Edwards Lifesciences Fund is supporting a growing number of organizations that strengthen our communities and help us in the fight against cardiovascular disease, further extending Edwards' reach and impact around the world."
Gifts from The Edwards Lifesciences Fund are categorized as either strategic or community grants. Strategic grants support programs or projects that expand awareness of cardiovascular disease, its prevention and treatment or enhance support and access to care for under-served cardiovascular patients. Community grants support programs or projects that provide opportunities for Edwards' employee involvement, help strengthen the community and improve the quality of life.
During 2007, The Edwards Lifesciences Fund has awarded more than $2 million in strategic grants, including:
-- A $100,000 grant to Surgeons of Hope Foundation to support a
humanitarian medical mission in Maputo and Dakar, Africa, for
providing much-needed cardiovascular care to this underserved
population.
-- A $100,000 grant to The Larry King Cardiac Foundation to support the
organization's goal to "Save a Heart a Day" by providing cardiac
treatment for individuals in the U.S. who, due to limited means or no
insurance, would otherwise be unable to receive the care they need.
-- A $100,000 grant to the Alliance for Aging Research to fund physician
education about the under-diagnosis and under-treatment of aortic
stenosis and increase awareness about treatment options for seniors
suffering from this disease.
The Edwards Lifesciences Fund also awarded more than $300,000 in community grants in 2007, including:
-- Grants to the American Heart Association for the Orange County and
Puerto Rico Heart Walks, which will help generate funds for
cardiovascular research and education programs in these regions.
-- A grant to Heart to Heart Mission, which will use the funds to provide
free cardiac surgery for patients in the Dominican Republic who cannot
afford treatment.
-- A grant to Goodwill Industries of Orange County to support the
Assistive Technology Institute, which was established to educate
public school teachers and parents about the latest communication
technology available to help children with disabilities.
Earlier this year, the company announced a $5 million multi-year grant to the University of California, Irvine to establish The Edwards Lifesciences Center for Advanced Cardiovascular Technology.
The complete list of organizations that received grants from The Edwards Lifesciences Fund is available at http://www.edwards.com/edwardsfund.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and registered in the United States Patent and Trademark Office.
Source: Edwards Lifesciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
